NDC 43598-061-11 - ziprasidone mesylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-061
- Requested NDC
- 43598-061-11
- Package NDCs from labels
- 43598-061-11, 43598-061-58
- Manufacturer
- Dr.Reddy's Laboratories, Inc. | Gland Pharma Limited
- Effective date
- 2021-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ziprasidone mesylate - Dr.Reddy's Laboratories, Inc. | Gland Pharma Limited | Dr.Reddy's Laboratories, Inc. | Gland Pharma Limited | 2021-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-061-11 | ziprasidone mesylate | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 | |
| 43598-061-58 | ziprasidone mesylate | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43598-061-11 | EA - Each | 43598-061 | 35ef85ad-4330-4b1c-9a31-cfa549440cd4 | 1 | 2022-05-04 |
| 43598-061-58 | EA - Each | 43598-061 | 4b0ce51e-1c2b-40a0-92ef-31e0f33c5116 | 1 | 2022-05-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 1ffd16c3-25ac-4839-9ea9-4efd32926b95 | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Novadoz Pharmaceuticals LLC | 90b35a26-ab65-4c39-b97f-55c8c0e34b0b | 2025-08-25 | Boxed warning, Warnings, Adverse reactions | 351223 3X6SAX83JZ |
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | Fosun Pharma USA Inc. | b28a4f3d-0aae-050d-e053-2995a90aa4a6 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| Ziprasidone Mesylate | ZIPRASIDONE MESYLATE | Fosun Pharma USA Inc. | 90f55022-8d58-4bfb-9464-9bf11395ae17 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Gland Pharma Limited | 77a10f48-e300-465f-81b5-54be38daa4b3 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ZIPRASIDONE MESYLATE | ZIPRASIDONE MESYLATE | HF Acquisition Co LLC, DBA HealthFirst | c75971f8-9640-a6e8-e053-2995a90af654 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Dr.Reddy's Laboratories, Inc. | 3cb79985-1207-602e-2dda-a118133b4c60 | 2021-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 351223 3X6SAX83JZ |
| ziprasidone mesylate | ZIPRASIDONE MESYLATE | Dr.Reddy's Laboratories, Inc. | 6fd6fc45-20c4-e223-3532-ce37aa02b71c | 2021-07-30 | Boxed warning, Warnings, Adverse reactions | ANDA211908 43598-061-11 43598-061-58 43598-061 43598006111 351223 b94a787b-0592-ac3d-b887-c706d571f6e8 6fd6fc45-20c4-e223-3532-ce37aa02b71c 3X6SAX83JZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.